Biotech investors seemed to be taking the sudden departure of a top Food and Drug Administration official late Tuesday as a ...

The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...

On June 7, the U.S. Food and Drug Administration granted "accelerated approval" to Biogen's new Alzheimer's medication, aducanumab, two years after the company halted its first set of Phase 3 ...